Chile - Hospital Average Length of Stay for Malignant Neoplasm of Prostate
Since 2014, Chile Hospital Average Length of Stay for Malignant Neoplasm of Prostate fell by 0.9% year on year. In 2019, the country was ranked number 15 among other countries in Hospital Average Length of Stay for Malignant Neoplasm of Prostate with 6.6 Days. South Korea topped the ranking with 15.9 Days in 2019, that is stable versus 2018. New Zealand, Lithuania and Slovakia respectively ranked number 2, 3 and 4 in this ranking. New Zealand witnessed the best average annual growth at +2.2% per year, while Mexico was the worst growing country at -8.8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 6.60 |
| 2018 | 6.70 |
| 2017 | 6.60 |
| 2016 | 6.50 |
| 2015 | 6.70 |
Download all data from 2001 to 2019
How does Chile rank in Hospital Average Length of Stay for Malignant Neoplasm of Prostate?
| # | 32 Countries | Days | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
15.90 | 2019 | +0.0 % | -0.9 % | View data | |
| 2 |
#2
New Zealand
|
11.60 | 2019 | -0.8 % | +2.2 % | View data | |
| 13 |
#13
Switzerland
|
6.70 | 2019 | -1.5 % | -3.0 % | View data | |
| 15 |
#15
Chile
|
6.60 | 2019 | -1.5 % | -0.9 % | View data | |
| 16 |
#16
Austria
|
6.40 | 2019 | -3.0 % | -0.6 % | View data | |